New vaccine aims to shield kids from painful hand, foot and mouth disease
NCT ID NCT06063057
First seen Jan 19, 2026 · Last updated Jun 08, 2026 · Updated 23 times
Summary
This study tests a new vaccine designed to protect against hand, foot and mouth disease and herpangina, which are common viral infections in children. The trial includes healthy adults and children aged 6 months to 59 years, and will check if the vaccine is safe and triggers a strong immune response. The vaccine targets two main viruses (EV71 and CA16) that cause these illnesses.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAND, FOOT AND MOUTH DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dayao County Center for Disease Control and Prevention
Chuxiong, Yunnan, China
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.